Pharmacological treatment of presbyopia: A systematic review
European Journal of Translational Myology · 19.09.2022 · 32 (3)
DOI: 10.4081/ejtm.2022.10781 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Translational Myology, online erschienen am 19.09.2022. Verfasst von Negin Haghpanah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Undergraduate Master of Pharmacy, Faculty of Science Engineering and Computing, School of Life Sciences, Pharmacy and Chemistry, Department of Pharma…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The aim of this study was to identify the efficacy of drug agents for pharmacological Treatment of Presbyopia. Published research papers were reviewed using the relevant terms in PubMed, Science direct, Google scholar, Medline, Google patent, Ovid, Cochrane Database of Systematic Reviews, Scopus. In the initial search, 2270 records were obtained. By removing duplicate articles and all articles that did not meet the inclusion criteria or were inappropriate due to indirect relevance to the subject, 44 studies were selected. It should be noted that all studies had inclusion criteria. There are a number of topical pharmacological agents available for treating presbyopia such as FOV Tears and PresbiDrop. They consist of parasympathetic agent and non-steroidal anti-inflammatory drugs (NSAIDs), to contract the ciliary and pupil muscle and restore the accommodation. Another example of topical pharmacological agent is EV06. It is a lens-softening eye drop which can affect the rigid lens in presbyopia. Currently there is no pharmacological agent available to treat presbyopia. Although there are limited number of peer-reviewed articles available, the outcome for future agents under investigation are promising.
Autor:innen und Institutionen
- Undergraduate Master of Pharmacy, Faculty of Science Engineering and Computing, School of Life Sciences, Pharmacy and Chemistry, Department of Pharmacy, Kingston University, London. nigi.hagh@gmail.com.
- Faculty of Science, Engineering and Computing, School of Life Sciences, Pharmacy and Chemistry, Department of Pharmacy, Kingston University , London. haghn455@gmail.com.
Zitieren
APA
Haghpanah, N., & Alany, R. (2022). Pharmacological treatment of presbyopia: A systematic review. European Journal of Translational Myology, 32(3). https://doi.org/10.4081/ejtm.2022.10781
Vancouver
Haghpanah N, Alany R. Pharmacological treatment of presbyopia: A systematic review. European Journal of Translational Myology. 2022;32(3). doi:10.4081/ejtm.2022.10781
BibTeX
@article{Haghpanah2022,
author = {Haghpanah, Negin and Alany, Raid},
title = {Pharmacological treatment of presbyopia: A systematic review},
journal = {European Journal of Translational Myology},
year = {2022},
volume = {32},
number = {3},
doi = {10.4081/ejtm.2022.10781}
}
EUVIMED